
Getting an influenza vaccine is one way to prevent and reduce the risk of severe complications from the flu. Besides the injection, there is also a nasal spray influenza vaccine. What are its pros and cons, and who is it suitable for?
The nasal spray influenza vaccine (Live Attenuated Influenza Vaccine: LAIV) was developed to provide convenience and build immunity without the pain of traditional injections. It has the following advantages and disadvantages.
The nasal spray vaccine is generally very safe, but some may experience mild side effects such as nasal congestion, runny nose, or low-grade fever. These symptoms are usually mild and resolve within 1–3 days.
Influenza viruses continuously change strains. Annual vaccination, whether by injection or nasal spray, is important to ensure the body’s immunity matches the circulating virus that year. The nasal spray influenza vaccine (LAIV) is another suitable option for people aged 2–49, especially children and adolescents. Its benefits include needle-free administration, immunity at the virus entry point, and high effectiveness in reducing infection rates and disease severity, comparable to injectable vaccines.
Information provided by Dr. Surawat Homwiset, Pediatric Allergist and Immunologist, Vejthani International Hospital.